Wellesley, MA, United States of America

Miranda Chapman

This inventor holds 5 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Baxalta Gmbh, Takeda Pharmaceutical Company Limited. Active years: 2020-2026.

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • San Francisco, CA (US) (2020)
  • Wellesley, MA (US) (2021 - 2024)

Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Miranda Chapman

Introduction

Miranda Chapman is a notable inventor based in Wellesley, MA (US). She has made significant contributions to the field of medicine, particularly in the treatment of severe von Willebrand disease. With a total of 5 patents to her name, her work has the potential to improve patient outcomes in critical health situations.

Latest Patents

One of her latest patents focuses on the treatment of gastrointestinal bleeding in patients with severe von Willebrand disease. This invention involves administering recombinant von Willebrand Factor (rVWF) at doses ranging from about 40 IU/kg to about 100 IU/kg. The method also includes the administration of recombinant Factor VIII (rFVIII) as part of the first dose. This innovative approach aims to provide a more effective treatment option for patients suffering from this condition.

Career Highlights

Throughout her career, Miranda has worked with prominent companies in the pharmaceutical industry. Notably, she has been associated with Baxalta GmbH and Takeda Pharmaceutical Company Limited. Her experience in these organizations has allowed her to develop and refine her inventions, contributing to advancements in medical treatments.

Collaborations

Miranda has collaborated with several professionals in her field, including Bettina Ploder and Bruce Ewenstein. These partnerships have facilitated the exchange of ideas and expertise, further enhancing her innovative work.

Conclusion

Miranda Chapman is a pioneering inventor whose contributions to the treatment of severe von Willebrand disease are noteworthy. Her patents reflect her commitment to improving healthcare solutions, and her collaborations with industry professionals underscore the importance of teamwork in innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…